Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment

Update on the Complications and Management of Canine Babesiosis

Babesia canis and B. gibsoni are responsible for canine babesiosis throughout the world. Babesia canis consists of a group of three biologically different subspecies, namely B. c. canis, B. c. vogeli, and B. c. rossi. Babesia gibsoni is subdivided into 2 subspecies: the North American and Asian subspecies. Babesia c. canis is found in Europe, B. c. vogeli in northern Africa, North America and S...

Canine babesiosis.

Babesiosis is a tick-borne disease affecting humans and many domestic and wild animals. Domestic animals showing appreciable morbidity and mortality include dogs, cats, cattle and horses. Both canine and feline babesiosis are diseases characterised by haemolytic anaemia, icterus and haemoglobinuria. Canine babesiosis can range from chronic or subclinical to peracute and fatal, depending on the ...

Antibabesial Treatment Protocols against Canine Babesiosis

Canine babesiosis is an important tick-borne disease caused by hemoprotozoan parasites of the genus Babesia, and the predominant species infecting dogs is Babesia gibsoni. The disease has been identified worldwide and is now recognized as a serious emergent disease in dogs. Although the incidence of canine babesiosis has been increasing, effective and crucial therapeutic modality is unavailable...

Thrombocytopaenia in canine babesiosis and its clinical usefulness.

Canine babesiosis is a common cause of thrombocytopaenia but there are few formal studies that have investigated this haematological finding in dogs. Thrombocyte counts from full blood counts were retrospectively analysed for the years 1996-2002. Thrombocyte counts and mean platelet volumes of dogs with babesiosis were compared with those of dogs, seen over the same period of time, that did not...

Successful treatment of babesiosis in a horse